ASTELLAS-015K-CL-RAJ3

Study Sponsor: Astellas

Study Title

Phase 3 Study of ASP015K - A Randomized, Double-blind, Placebo-controlled Confirmatory Study of the Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis Who Had an Inadequate Response to DMARDs -

Medicine or Vaccine (generic name)

peficitinib hydrobromide

Sponsor Identification Number

015K-CL-RAJ3

Trial Registry Identification Number(#'s)

NCT02308163

Medical Condition

Rheumatoid Arthritis

Phase

Phase 3

Link to Astellas Study Register

https://www.clinicaltrials.astellas.com/study/015K-CL-RAJ3

Link to study details on ClinicalTrials.gov (if available)

https://clinicaltrials.gov/ct2/show/NCT02308163

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

July 2020